Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 181.05M P/E - EPS this Y 2.60% Ern Qtrly Grth -
Income -166.43M Forward P/E -1.97 EPS next Y 50.40% 50D Avg Chg -20.00%
Sales 162.47M PEG - EPS past 5Y - 200D Avg Chg -52.00%
Dividend N/A Price/Book 13.28 EPS next 5Y - 52W High Chg -79.00%
Recommedations 2.50 Quick Ratio 1.88 Shares Outstanding 48.12M 52W Low Chg 9.00%
Insider Own 3.17% ROA -30.87% Shares Float 39.41M Beta 1.24
Inst Own 106.45% ROE -1,028.56% Shares Shorted/Prior 6.04M/5.35M Price 3.83
Gross Margin 35.72% Profit Margin -102.44% Avg. Volume 1,492,277 Target Price 1.67
Oper. Margin -75.83% Earnings Date Feb 26 Volume 1,114,010 Change -11.25%
About NanoString Technologies, Inc.

NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

NanoString Technologies, Inc. News
02/09/24 NanoString Announces Completion of Financing to Support Restructuring Process
02/05/24 Nanostring files for bankruptcy protection, explores possible sale
02/04/24 NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
06:00 AM NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
01/07/24 NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
01/05/24 NanoString Reports Inducement Grants Under Nasdaq Listing Rules
01/04/24 NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference
12/25/23 7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight
11/19/23 NanoString Comments on Delaware District Court Verdict
11/16/23 Here’s What Led Conestoga Capital Advisors to Sell Nanostring Technologies (NSTG)
11/09/23 NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience
11/09/23 NanoString to Webcast Presentations from Upcoming Healthcare Conferences
11/07/23 NanoString Technologies, Inc. (NASDAQ:NSTG) Q3 2023 Earnings Call Transcript
11/06/23 NanoString (NSTG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
11/06/23 NanoString Technologies Inc (NSTG) Reports Q3 2023 Earnings: Revenue Grows by 63% Year on Year
11/06/23 NanoString Technologies Releases Operating Results for Third Quarter of 2023
11/04/23 NanoString Technologies' Recent Gains Improve Losses On Insider Purchases Worth US$6.21m
11/02/23 Earnings Preview: Capricor Therapeutics (CAPR) Q3 Earnings Expected to Decline
04:00 AM NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available
10/30/23 NanoString Technologies (NSTG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
GRAY R BRADLEY President and CEO President and CEO May 25 Buy 5.80 30,000 174,000 338,395 05/30/23
Bailey K Thomas Chief Financial Offi.. Chief Financial Officer May 26 Buy 5.763 15,000 86,445 75,388 05/30/23
Norden Gregory Director Director Apr 27 Option 8.45 8,768 74,090 32,568 04/28/23
FINNEY ELISHA W Director Director Jun 17 Sell 12.41 1,945 24,137 6,595 06/21/22
Bailey K Thomas Chief Financial Offi.. Chief Financial Officer Mar 10 Sell 33.81 5,000 169,050 16,105 03/11/22
GRAY R BRADLEY President and CEO President and CEO Mar 06 Option 0 24,526 198,596 03/09/22
GRAY R BRADLEY President and CEO President and CEO Mar 06 Sell 33.06 9,667 319,591 188,929 03/09/22
BEECHEM JOSEPH M SVP, Research & Deve.. SVP, Research & Development Mar 06 Option 0 6,505 85,399 03/09/22
BEECHEM JOSEPH M SVP, Research & Deve.. SVP, Research & Development Mar 06 Sell 33.06 2,968 98,122 82,431 03/09/22
Bailey K Thomas Chief Financial Offi.. Chief Financial Officer Mar 06 Option 0 7,753 24,163 03/09/22
Bailey K Thomas Chief Financial Offi.. Chief Financial Officer Mar 06 Sell 33.06 3,058 101,097 21,105 03/09/22
GRAY R BRADLEY President and CEO President and CEO Sep 10 Sell 58.15 33,334 1,938,372 135,824 09/10/21
GRAY R BRADLEY President and CEO President and CEO Sep 10 Option 6.72 12,500 84,000 169,158 09/10/21
GRAY R BRADLEY President and CEO President and CEO Apr 13 Sell 66.14 26,863 1,776,719 169,803 04/13/21
GRAY R BRADLEY President and CEO President and CEO Apr 13 Sell 66.32 8,817 584,743 196,666 04/13/21
GRAY R BRADLEY President and CEO President and CEO Apr 13 Option 4.32 25,000 108,000 162,507 04/13/21
GRAY R BRADLEY President and CEO President and CEO Apr 13 Sell 62.52 33,333 2,083,979 129,174 04/13/21
BROWN J. CHAD SVP, Sales & Marketi.. SVP, Sales & Marketing Apr 13 Sell 68.78 4,948 340,323 04/13/21
BROWN J. CHAD SVP, Sales & Marketi.. SVP, Sales & Marketing Apr 13 Sell 66.32 1,335 88,537 9,702 04/13/21
BEECHEM JOSEPH M SVP, Research & Deve.. SVP, Research & Development Apr 13 Sell 66.14 10,035 663,715 80,035 04/13/21
BEECHEM JOSEPH M SVP, Research & Deve.. SVP, Research & Development Apr 13 Sell 66.32 1,778 117,917 90,070 04/13/21
Bailey K Thomas Chief Financial Offi.. Chief Financial Officer Apr 13 Sell 66.32 1,335 88,537 19,316 04/13/21
HERSHBERG ROBERT Director Director Feb 18 Option 11.2 1,188 13,306 3,078 02/18/21
HERSHBERG ROBERT Director Director Feb 18 Sell 81.17 1,188 96,430 1,890 02/18/21
Malloy Kirk Director Director Jan 13 Option 11.92 2,500 29,800 3,490 01/13/21
Malloy Kirk Director Director Jan 13 Sell 66.53 2,500 166,325 990 01/13/21